The Basel-based biotechnology company Actelion will have a new global head after the acquisition by Johnson & Johnson takes effect. Jane Griffiths has been a…
The Basel-based data management company closed a USD 10 million financing round. The new funds will go towards accelerating its clinical and genomic data platform.
Polyphor aims high. The Allschwil-based biotech company wants to bring the first new class of antibiotics into clinical use; the last one reached clinics some…
Genentech, an American subsidiary of the Basel-based pharmaceutical company Roche, will start a second Phase 3 clinical trial for its Alzheimer’s therapy crenezumab.
The Basel-based venture capital firm BioMedPartners has raised CHF 75 million in the first closing of their fund BioMedInvest III, a healthcare venture capital fund…